Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
London, UK, September 9, 2026 – Athernal Bio, a UK biotechnology company pioneering cancer interception, today announced it has been awarded a grant of nearly £700,000 through Innovate UK’s Growth Catalyst – Investor Partnerships programme. The non-dilutive funding will accelerate the development of Athernal’s lead immunotherapy programme, designed to intercept the earliest stages of acute myeloid leukaemia (AML) before cancer becomes established. The award comes alongside continued support from existing investor Delin Ventures.
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
London, UK, September 9, 2026 – Athernal Bio, a UK biotechnology company pioneering cancer interception, today announced it has been awarded a grant of nearly £700,000 through Innovate UK’s Growth Catalyst – Investor Partnerships programme. The non-dilutive funding will accelerate the development of Athernal’s lead immunotherapy programme, designed to intercept the earliest stages of acute myeloid leukaemia (AML) before cancer becomes established. The award comes alongside continued support from existing investor Delin Ventures.
Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA
Reception of the First Two Falcon Albatros Aircraft by the DGA
Dassault Aviation : Réception des deux premiers Falcon Albatros par la DGA
Réception des deux premiers Falcon Albatros par la DGA
Cosmetic Dyes Market Size to Surpass USD 731.3 Million by 2035; Driven by Clean Beauty Demand | SNS Insider
U.S. Cosmetic Dyes Market to Reach USD 127.5 Million by 2035; Europe to Grow to USD 251.98 Million as Natural Colorants Gain Ground
Premium Catering (Holdings) Limited Receives NASDAQ Notice Related to Late Filing of Its Interim Report
New York, NY, Sept. 09, 2026 (GLOBE NEWSWIRE) — Premium Catering (Holdings) Limited (NASDAQ: PC, or the “Company”), today announced that today announced that it has received a letter from the Nasdaq Stock Market, dated September 4, 2026 (the “Delinquency Letter”), notifying the Company that it is not in compliance with the requirements for continued listing set forth in NASDAQ Listing Rule 5250(c)(1) because it did not timely file its interim report on Form 6-K containing an interim balance sheet and income statement for its fiscal half year ended December 31, 2025 (the “2026 Interim Report”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires that listed companies timely file all required periodic financial reports with the Securities and Exchange Commission. In accordance with Nasdaq Listing Rules, the Company has 60 calendar days from the date of the Delinquency Letter to submit a plan to regain compliance with the Rule (the “Compliance Plan”). If Nasdaq accepts the Compliance Plan, Nasdaq may grant the Company an extension until 180 calendar days from the date of the 2026 Interim Report’s due date, or December 28, 2026, to regain compliance. The Company intends to submit the Compliance Plan within the prescribed 60-day period.
Finch Completes Strategic Merger to Build AI Commercialization Infrastructure Simultaneously Announces Close of Pre-A Funding Round
AI Asset-Tokenization Platform and Task-Dispatch Network Combine to Lay Transaction and Payment Rails for the AI Commercialization Economy
Tradition Announces Partnership With Affin Moneybrokers to Support Malaysian Market Data
SINGAPORE, Sept. 09, 2026 (GLOBE NEWSWIRE) — Tradition today announced a strategic partnership with Affin Moneybrokers Sdn. Bhd., one of Malaysia’s leading interbank money brokers, under which Tradition will provide market data infrastructure, pricing technology and distribution capabilities to support Affin’s continued growth in the Malaysian financial markets.
AI Evaluation Platform Market Size to Surpass $16.54 Billion by 2035 | SNS Insider
Pharming Group to participate in September investor conferences
Cimplifi Expands UK Presence with Appointment of Cheza Ross as Director, Business Development
Cimplifi, a leader in AI orchestration for eDiscovery and contract analytics, today announced that Cheza Ross has joined the company as director, business development, further strengthening the commitment of Cimplifi to serving clients across the United Kingdom and Europe
Early Warning Press Release Regarding Acquisition of Common Shares in Carbon Streaming Corporation by Marin Katusa
ISP Global Capital: Fort Technology Reports Record Revenue Growth and Closes Logia USA Acquisition
Concentrix Strengthens Enterprise Risk and Compliance Capabilities with Acquisition of CastleHill
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer’s patients anticipated by year-end 2027 or first quarter of 2028
Wawanesa receives regulatory approval to acquire Everest Insurance Company of Canada
WINNIPEG, Manitoba, Sept. 08, 2026 (GLOBE NEWSWIRE) — The Wawanesa Mutual Insurance Company (“Wawanesa”) announced today it has received all required regulatory approvals to complete its acquisition of Everest Insurance Company of Canada (“Everest Canada”) from Everest Group, Ltd. (“Everest”).